Journal
METABOLOMICS
Volume 10, Issue 5, Pages 897-908Publisher
SPRINGER
DOI: 10.1007/s11306-014-0642-1
Keywords
Urease; Urine; Gas chromatography-mass spectrometry; Metabolomics; Statistics
Categories
Funding
- NIH NIDDK [DP3 DK094343]
- Department of Energy's (DOE) Office of Biological and Environmental Research at Pacific Northwest National Laboratory (PNNL) in Richland, Washington
- DOE [DE-AC05-76RLO 1830]
Ask authors/readers for more resources
Urease pre-treatment of urine has been utilized since the early 1960s to remove high levels of urea from samples prior to further processing and analysis by gas chromatography-mass spectrometry (GC-MS). Aside from the obvious depletion or elimination of urea, the effect, if any, of urease pre-treatment on the urinary metabolome has not been studied in detail. Here, we report the results of three separate but related experiments that were designed to assess possible indirect effects of urease pre-treatment on the urinary metabolome as measured by GC-MS. In total, 235 GC-MS analyses were performed and over 106 identified and 200 unidentified metabolites were quantified across the three experiments. The results showed that data from urease pre-treated samples (1) had the same or lower coefficients of variance among reproducibly detected metabolites, (2) more accurately reflected quantitative differences and the expected ratios among different urine volumes, and (3) increased the number of metabolite identifications. Overall, we observed no negative consequences of urease pre-treatment. In contrast, urease pre-treatment enhanced the ability to distinguish between volume-based and biological sample types compared to no treatment. Taken together, these results show that urease pre-treatment of urine offers multiple beneficial effects that outweigh any artifacts that may be introduced to the data in urinary metabolomics analyses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available